Gold Futures Touch $4,579: The 54th Record High of 2025
Gold futures reached $4,579.60 per ounce on December 27, marking the 54th record close of 2025. The precious metal is up 70% year-to-date, its best performance since 1979.
254 articles found for "passive income"
Year-End Portfolio Checkup: What 2025's Winners and Losers Mean for 2026
With days left in 2025, review the year's biggest winners (gold, Nvidia, small caps) and losers (Nike, Oracle) to position your portfolio for 2026.
Gold Hits $4,469: The Yellow Metal's Best Year Since 1979
Gold futures hit $4,469 per ounce, up nearly 70% for 2025. Geopolitical tensions, Fed rate cuts, and dollar weakness are driving the historic rally.
U.S. Economy Grew at 4.3% in Q3: The Fastest Pace in Two Years
The U.S. economy expanded at a 4.3% annualized rate in Q3 2025, far exceeding expectations and complicating the Fed's rate-cut calculus for 2026.
Vanguard's Crypto U-Turn: 50 Million Customers Can Now Buy Bitcoin ETFs
Vanguard reverses its longtime crypto ban, opening Bitcoin and Ethereum ETF access to its 50 million brokerage customers. The move signals mainstream adoption.
Fed's Hammack Signals Rates on Hold 'for Months': What It Means for Investors
Cleveland Fed President Beth Hammack signals the Fed may hold rates steady for months ahead. Markets now pricing 75% chance of no January move.
FedEx Beats Expectations and Confirms Freight Spinoff on Track for June 2026
FedEx reports Q2 earnings beat with 19% EPS growth as freight spinoff preparations advance. Stock rises on raised guidance despite MD-11 fleet headwinds.
Micron Soars 12% on Blowout Earnings: The AI Memory Supercycle Is Real
Micron stock jumped 12% after posting record earnings and guiding for $18.7 billion in Q2 revenue. The AI memory boom shows no signs of slowing.
Hershey Gets a Sweet Upgrade as Cocoa Costs Finally Ease
Morgan Stanley upgraded Hershey to overweight with a $211 price target as cocoa cost pressures ease. Here's why the chocolate maker may be turning a corner.
Pfizer's 2026 Outlook Disappoints: COVID Hangover Continues to Drag on Growth
Pfizer's 2026 outlook falls short of Wall Street estimates as COVID-19 product sales decline by $1.5 billion. Here's what the guidance means for pharma investors.
Private Credit's $3 Trillion Boom Has Jeffrey Gundlach Worried
Billionaire investor Jeffrey Gundlach compares the $3 trillion private credit market to pre-2008 CDOs. Here's why the 'Wild West' of finance has regulators concerned.
Nike Earnings Preview: Can the Swoosh Finally Stage a Comeback?
Nike reports Q2 FY26 earnings Thursday after a brutal year that saw shares drop 8% and a Moody's downgrade. Here's what investors should watch for.